Selected article for: "CP feasibility acceptability and feasibility acceptability"

Author: van Griensven, Johan; De Weiggheleire, Anja; Delamou, Alexandre; Smith, Peter G.; Edwards, Tansy; Vandekerckhove, Philippe; Bah, Elhadj Ibrahima; Colebunders, Robert; Herve, Isola; Lazaygues, Catherine; Haba, Nyankoye; Lynen, Lutgarde
Title: The Use of Ebola Convalescent Plasma to Treat Ebola Virus Disease in Resource-Constrained Settings: A Perspective From the Field
  • Document date: 2016_1_1
  • ID: riw5xs3j_36
    Snippet: Long-term studies are also required to document better the feasibility and acceptability of CP donation outside of a research setting, to assess the willingness of survivors to become CP donors and to identify any negative immunological, medical, or psychosocial effects of repeated CP donations. Longer followup of CP treated patients is also indicated to detect late adverse events......
    Document: Long-term studies are also required to document better the feasibility and acceptability of CP donation outside of a research setting, to assess the willingness of survivors to become CP donors and to identify any negative immunological, medical, or psychosocial effects of repeated CP donations. Longer followup of CP treated patients is also indicated to detect late adverse events.

    Search related documents:
    Co phrase search for related documents
    • acceptability feasibility and long term: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acceptability feasibility and research setting: 1, 2
    • adverse event and cp donor: 1
    • adverse event and late adverse event: 1
    • adverse event and long term: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • adverse event and long term study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • adverse event and research setting: 1, 2, 3
    • cp donor and research setting: 1, 2
    • late adverse event and long term: 1
    • late adverse event and long term study: 1
    • long term and research setting: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • long term and treat patient: 1, 2, 3, 4
    • long term study and research setting: 1, 2